{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:36:20Z","timestamp":1787776580220,"version":"build-2784847793"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1093\/brain\/awt048","type":"journal-article","created":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T02:42:39Z","timestamp":1364870559000},"page":"1116-1127","source":"Crossref","is-referenced-by-count":89,"title":["The Medical Research Council Prion Disease Rating Scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies"],"prefix":"10.1093","volume":"136","author":[{"given":"Andrew G.B.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lukic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claire","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gorham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gosala S.","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rudge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,4,1]]},"reference":[{"key":"key\n\t\t\t\t20170405090020_awt048-B1","article-title":"Perth: RUMM Laboratory; 2030. 2008. Rasch Unidimensional Measurement Model","author":"Andrich","year":"2008"},{"key":"key\n\t\t\t\t20170405090020_awt048-B2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/09638288809164103","article-title":"The Barthel ADL Index: a reliability study","volume":"10","author":"Collin","year":"1988","journal-title":"Int Disabil Stud"},{"key":"key\n\t\t\t\t20170405090020_awt048-B3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","article-title":"Prion diseases of humans and animals: their causes and molecular basis","volume":"24","author":"Collinge","year":"2001","journal-title":"Ann Rev Neurosci"},{"key":"key\n\t\t\t\t20170405090020_awt048-B4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1474-4422(09)70049-3","article-title":"Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial","volume":"8","author":"Collinge","year":"2009","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170405090020_awt048-B5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"key\n\t\t\t\t20170405090020_awt048-B7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1474-4422(07)70290-9","article-title":"Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations","volume":"6","author":"Hobart","year":"2007","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170405090020_awt048-B8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.1215579","article-title":"PrP antibodies do not trigger mouse hippocampal neuron apoptosis","volume":"335","author":"Klohn","year":"2012","journal-title":"Science"},{"key":"key\n\t\t\t\t20170405090020_awt048-B9","first-page":"56","article-title":"Functional evaluation: the Barthel Index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"key":"key\n\t\t\t\t20170405090020_awt048-B10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1090187","article-title":"Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis","volume":"302","author":"Mallucci","year":"2003","journal-title":"Science"},{"key":"key\n\t\t\t\t20170405090020_awt048-B11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/emboj\/21.3.202","article-title":"Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration","volume":"21","author":"Mallucci","year":"2002","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20170405090020_awt048-B12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2007.01.005","article-title":"Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice","volume":"53","author":"Mallucci","year":"2007","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170405090020_awt048-B13","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/WNL.0b013e3182364890","article-title":"PRION-1 scales analysis supports use of functional outcome measures in prion disease","volume":"77","author":"Mead","year":"2011","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170405090020_awt048-B14","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(09)70215-7","article-title":"Clinical trials and methodological problems in prion diseases reply","volume":"8","author":"Mead","year":"2009","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170405090020_awt048-B15","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170405090020_awt048-B16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1871526510909010048","article-title":"Preventing prion pathogenicity by targeting the cellular prion protein","volume":"9","author":"Nicoll","year":"2009","journal-title":"Infect Disord Drug Targets"},{"key":"key\n\t\t\t\t20170405090020_awt048-B17","doi-asserted-by":"crossref","first-page":"17610","DOI":"10.1073\/pnas.1009062107","article-title":"Pharmacological chaperone for the structured domain of human prion protein","volume":"107","author":"Nicoll","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170405090020_awt048-B18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/003693305700200401","article-title":"Cerebral vascular accidents in patients over the age of 60","volume":"2","author":"Rankin","year":"1957","journal-title":"Scott Med J"},{"key":"key\n\t\t\t\t20170405090020_awt048-B19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness - practical scale","volume":"2","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170405090020_awt048-B20","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/art.23108","article-title":"The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper?","volume":"57","author":"Tennant","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170405090020_awt048-B21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","article-title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease","volume":"422","author":"White","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170405090020_awt048-B22","article-title":"The revision of the surveillance case definition for variant creutzfeldt-jakob disease (vCJD). WHO manual for surveillance of human transmissible spongiform encephalopathies","author":"WHO","year":"2001"},{"key":"key\n\t\t\t\t20170405090020_awt048-B23","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/136\/4\/1116\/11140117\/awt048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T12:50:15Z","timestamp":1562849415000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awt048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,1]]},"published-print":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awt048","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}